Case Studies
Funded startups don’t need paperwork.
They need defensibility.
Below are examples of how we’ve helped venture-backed founders turn patent strategy into fundraising strength.
AI SaaS Startup – Preparing for Series A
The Situation
A Seed-funded AI SaaS startup had raised $3.2M and was preparing for a Series A round.
They had:
- A provisional patent filed quickly before fundraising
- Rapid product expansion underway
- Increasing competitive filings in their space
- Investor questions around defensibility
They needed clarity before entering due diligence.
The Risk
Their original provisional:
- Lacked structured claim depth
- Didn’t anticipate roadmap expansion
- Provided limited layered coverage
- Could weaken non-provisional strength
If left unaddressed, this could have:
- Reduced perceived defensibility
- Lowered valuation leverage
- Raised red flags during diligence
The Strategy
We:
- Conducted a full technical deep dive
- Reviewed competitor filings
- Restructured their non-provisional with layered claim coverage
- Built a continuation strategy for future features
- Mapped IP filings to product milestones
The goal was not just approval — but defensibility under scrutiny.
The Outcome
- Strong non-provisional filing aligned with roadmap
- Clear portfolio expansion plan
- Structured claim hierarchy
- Reduced exposure to competitive overlap
Fundraising Impact
During Series A due diligence:
- Investors viewed IP as structured and forward-thinking
- No major diligence concerns surfaced
- Portfolio design reinforced moat narrative
IP shifted from a potential weakness to a strategic asset.
MedTech Hardware Startup – Protecting Core Innovation Before Clinical Trials
The Situation
A venture-backed MedTech startup had raised $6M to develop a proprietary medical device.
They were:
- Entering clinical trial phases
- Planning international expansion
- Facing potential regulatory disclosures
- Preparing for strategic partnerships
Timing was critical.
The Risk
If filings were delayed:
- Public disclosures during trials could jeopardize protection
- International rights could be lost
- Competitors could design around weak claims
- Acquisition interest could weaken
In MedTech, protection depth directly impacts enterprise value.
The Strategy
We:
- Filed a comprehensive provisional covering core engineering elements
- Structured claims anticipating regulatory disclosures
- Developed a PCT strategy aligned with global expansion
- Created layered claims around device functionality
- Sequenced filings to preserve cost efficiency
The Outcome
- Priority secured before public exposure
- Strong claim coverage protecting core device components
- International filing roadmap in place
- Reduced competitive vulnerability
Fundraising & Partnership Impact
During strategic partnership discussions:
- IP strength reinforced negotiation leverage
- International protection supported expansion credibility
- Portfolio depth increased acquisition attractiveness
IP became part of their valuation narrative.
Repeat Founder – Second Exit, Smarter IP Strategy
The Situation
A second-time founder launching a new Deep Tech platform had previously exited a company.
This time, they:
- Raised $4M at Seed
- Wanted a proactive IP roadmap
- Understood the cost of reactive filings
- Planned for acquisition from day one
They wanted structure — not scrambling.
The Risk
In their previous company:
- IP was filed reactively
- Claims were narrow
- Continuation strategy was lacking
- Due diligence required additional filings
They wanted to avoid repeating those mistakes.
The Strategy
We:
Built a comprehensive IP roadmap aligned with 3-year growth projections
- Structured layered provisional + non-provisional strategy
- Designed continuation pathways for expansion
- Integrated competitor monitoring
- Created international staging plan
The Outcome
- Clear multi-year IP strategy
- Layered, defensible claim structure
- Reduced need for reactive filings
- Strong positioning for strategic exit
Exit Impact
When acquisition discussions began:
- IP portfolio appeared intentional and mature
- No emergency filings required
- Due diligence proceeded without IP-related disruption
The founder later described it as:
“Building IP like we were already preparing for acquisition.”
Why These Case Studies Matter
Funded startups operate under:
- Investor pressure
- Competitive filing environments
- Product velocity
- Public disclosures
- Due diligence scrutiny
IP done reactively creates exposure.
IP done strategically creates leverage.
